Please use this identifier to cite or link to this item:
|Title:||Immunoglobulin-M purification - challenges and perspectives|
|Source:||Gautam, S.,Loh, K.-C. (2011-11). Immunoglobulin-M purification - challenges and perspectives. Biotechnology Advances 29 (6) : 840-849. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biotechadv.2011.07.001|
|Abstract:||Extensive research in the past two decades has led to the realization of Immunoglobulin-M (IgM) as a potential therapeutic and diagnostic agent. In order to fully exploit the potential of IgM, large quantities, in a highly pure and active form, must be available at low cost for performing clinical trials, characterization studies and quantitative-structure activity analyses. The complex physico-chemical properties, in particular its large size and labile nature renders downstream purification of IgM difficult. This review discusses the limitations and challenges associated with the current IgM purification strategies and proposes future directions for research. The uniqueness of affinity chromatography, specifically biomimetic affinity chromatography for protein purification is highlighted and its potential for IgM purification is discussed. © 2011 Elsevier Inc.|
|Source Title:||Biotechnology Advances|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 5, 2017
WEB OF SCIENCETM
checked on Nov 1, 2017
checked on Dec 9, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.